Are Analysts Bullish about Chiasma, Inc. (NASDAQ:CHMA) after last week?

March 14, 2018 - By sdfsdfsdf

 Are Analysts Bullish about Chiasma, Inc. (NASDAQ:CHMA) after last week?

Chiasma, Inc. (NASDAQ:CHMA) Ratings Coverage

Among 3 analysts covering Chiasma (NASDAQ:CHMA), 1 have Buy rating, 1 Sell and 1 Hold. Therefore 33% are positive. Chiasma had 6 analyst reports since August 10, 2015 according to SRatingsIntel. Barclays Capital downgraded Chiasma, Inc. (NASDAQ:CHMA) rating on Tuesday, January 17. Barclays Capital has “Underweight” rating and $2.50 target. The rating was initiated by Cowen & Co with “Outperform” on Monday, August 10. Barclays Capital downgraded it to “Equal-Weight” rating and $5.50 target in Monday, April 25 report. Barclays Capital initiated Chiasma, Inc. (NASDAQ:CHMA) on Monday, August 10 with “Overweight” rating. The rating was initiated by William Blair with “Outperform” on Monday, August 10. As per Monday, April 18, the company rating was downgraded by William Blair. Below is a list of Chiasma, Inc. (NASDAQ:CHMA) latest ratings and price target changes.

The stock decreased 1.59% or $0.03 during the last trading session, reaching $1.55. About 12,347 shares traded. Chiasma, Inc. (NASDAQ:CHMA) has declined 48.76% since March 14, 2017 and is downtrending. It has underperformed by 65.46% the S&P500.

Chiasma, Inc., a clinical-stage biopharmaceutical company, focuses on developing and commercializing oral forms of therapies using transient permeability enhancer technology platform. The company has market cap of $37.79 million. The firm offers octreotide capsules, which is in Phase III clinical trial for the treatment of acromegaly, a condition that results in the bodyÂ’s production of excess growth hormone under the MYCAPSSA name. It currently has negative earnings.

More notable recent Chiasma, Inc. (NASDAQ:CHMA) news were published by: which released: “Chiasma Inc.” on April 03, 2016, also with their article: “Chiasma Provides Update Regarding FDA’s Complete Response Letter for Mycapssa …” published on April 18, 2016, published: “Chiasma to Present at the Cowen and Company 38th Annual Health Care Conference” on February 28, 2018. More interesting news about Chiasma, Inc. (NASDAQ:CHMA) were released by: and their article: “Chiasma Inc. CHMA (US: Nasdaq)” published on July 10, 2015 as well as‘s news article titled: “Chiasma Announces Corporate Restructuring Plan and Provides Regulatory Update …” with publication date: June 14, 2016.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.